HIV-1 Tat: coping with negative elongation factors
- 31 August 1999
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 11 (4), 460-465
- https://doi.org/10.1016/s0952-7915(99)80077-6
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- RNA polymerase II as a control panel for multiple coactivator complexesCurrent Opinion in Genetics & Development, 1999
- NELF, a Multisubunit Complex Containing RD, Cooperates with DSIF to Repress RNA Polymerase II ElongationCell, 1999
- Structure and Function of the Human Transcription Elongation Factor DSIFJournal of Biological Chemistry, 1999
- Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription invitroThe EMBO Journal, 1998
- DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologsGenes & Development, 1998
- Evidence that Spt4, Spt5, and Spt6 control transcription elongation by RNA polymerase II in Saccharomyces cerevisiaeGenes & Development, 1998
- A CTD function linking transcription to splicingTrends in Biochemical Sciences, 1997
- Taking a new TAK on Tat transactivationGenes & Development, 1997
- Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitroGenes & Development, 1997
- P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitroGenes & Development, 1997